ODDB.org: Open Drug Database

Irinotecan Fresenius 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung -

Swissmedic Key	61246018	Registration Holder	Fresenius Kabi (Schweiz) AG
Name	Irinotecan Fresenius 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	28.01.2011
Original/Generic	Generic	Introduction of Sequence	28.01.2011
ATC-Classification	Irinotecan (L01CE02)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	91.81	Limitation	No

Deductible	10 %	Consumer price	116.25
Feedback	FB
GTIN	7680612460183	Medication Code	Synthetika
Pharmacode	7738396	Disponibility

Composition

irinotecani hydrochloridum trihydricum 100 mg, sorbitolum 225 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100mg / 5ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100 mg

Inactive agents	Dose
Acidum Hydrochloridum ad Ph
Lactic Acid
Natrii Hydroxidum ad Ph
Sorbitol	225mg / 5ml

Source

Data was imported : 11.07.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH